2025 Year-End Patient Centricity Review

Progress and Perspectives in Patient Centricity: 2025 Reflections

Patient centricity is a movement now. At Cactus Life Sciences, we don’t just follow the trend; we help set it. Here’s how your voices, our actions, and the industry’s bold steps made 2025 a landmark year...
Read More

Top Stories

Patient Centricity

The Evolution of Patient Centricity in Pharma

Patient centricity: A defining imperative in healthcare As...
AI in Scientific Publications

The Role of AI in Transforming Scientific

Scientific publishing is evolving rapidly with the advent of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Data-driven QMS Alignment-Feature image for the 30-sec video reel - AMDS

Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR

The latest EU-MDR guidelines are a step in the right direction, moving from a focus...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.